Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.

Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Lee, J, Choudhury, R
Formato:	Journal article
Lenguaje:	English
Publicado:	2010

Ejemplares similares

Rheumatoid arthritis: RA-lowering cardiovascular risk with statins
por: Lee, J, et al.
Publicado: (2010)

T cell genetics and rheumatoid arthritis (RA)
por: Wordsworth, P
Publicado: (1998)

Bone turnover in early rheumatoid arthritis (RA)
por: Sambrook, P, et al.
Publicado: (1985)

Concomitant use of statins in filgotinib-treated patients with rheumatoid arthritis
por: Taylor, PC, et al.
Publicado: (2021)

Interleukin 10 (IL-10) haplotypes are associated with rheumatoid arthritis (RA).
por: MacKay, K, et al.
Publicado: (2000)

Association of vascular function and estimated cardiovascular risk in patients with rheumatoid arthritis
por: Pieringer, H, et al.
Publicado: (2017)

The role of IL-10 in rheumatoid arthritis (RA) in two ethnically diverse populations.
por: MacKay, K, et al.
Publicado: (1999)

PARTICULAR GENETIC-VARIANTS OF TYPE-II COLLAGEN ARE NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA)
por: Pile, K, et al.
Publicado: (1992)

Brain natriuretic peptide (BNP) is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis (RA)
por: Harney, S, et al.
Publicado: (2005)

TEMPORAL TRENDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN THE UK WITH REFERENCE TO BEST PRACTICE
por: Edwards, C, et al.
Publicado: (2012)

Statins for people at low risk of cardiovascular disease reply
por: Mihaylova, B, et al.
Publicado: (2012)

Evolving the management of rheumatoid arthritis (eRA) through development of practical and educational tools
por: Van De Laar, M, et al.
Publicado: (2019)

Cardiovascular safety during treatment with baricitinib in rheumatoid arthritis
por: Taylor, P, et al.
Publicado: (2019)

Cardiovascular safety during treatment with baricitinib in rheumatoid arthritis
por: Weinblatt, M, et al.
Publicado: (2017)

Rapid and concurrent improvements in patient-reported outcomes of rheumatoid arthritis with baricitinib in RA-BEAM
por: Strand, V, et al.
Publicado: (2021)

Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study
por: Nikiphorou, E, et al.
Publicado: (2020)

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
por: Isaacs, JD, et al.
Publicado: (2022)

Subclinical atherosclerosis among rheumatoid arthritis patients without overt cardiovascular risk factors
por: Sulaiman Sahari, Narisa, et al.
Publicado: (2014)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
por: Maini, R, et al.
Publicado: (1995)

T-CELL RECEPTOR V-BETA-2 SEGMENT CODING POLYMORPHISM IS NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA)
por: Pile, K, et al.
Publicado: (1993)

Autoantibodies, autoimmune risk alleles and clinical associations in rheumatoid arthritis cases and non-RA controls in the electronic medical records
por: Liao, Katherine P., et al.
Publicado: (2014)

THE T-CELL RECEPTOR V-BETA-2 SEGMENT CODING POLYMORPHISM IS NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA)
por: Cornelis, F, et al.
Publicado: (1992)

Development of an in-vitro rheumatoid arthritis (RA) model and its application in anti-rheumatic drug testing
por: Tan, Kian Siong
Publicado: (2016)

Rheumatoid arthritis.
por: Feldmann, M, et al.
Publicado: (1996)

Rheumatoid arthritis
por: Taylor, P
Publicado: (2022)

Rheumatoid arthritis.
por: Wordsworth, P
Publicado: (1992)

A GENE INTERACTIVE WITH HLA-DR4 IN SUSCEPTIBILITY TO TYPE-I DIABETES IS NOT INVOLVED IN RHEUMATOID-ARTHRITIS (RA)
por: Pile, K, et al.
Publicado: (1992)

Statins and oxidative stress in the cardiovascular system
por: Margaritis, M, et al.
Publicado: (2017)

Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
por: Taylor, P, et al.
Publicado: (2019)

Rethinking cardiovascular prevention: cost-effective cholesterol lowering for statin-intolerant patients in Australia and the UK
por: Morton, JI, et al.
Publicado: (2025)

Immunotherapy for rheumatoid arthritis.
por: Taylor, P, et al.
Publicado: (2001)

Myocardial infarction in rheumatoid arthritis: The effects of traditional risk factors, anti-hypertensive and lipid-lowering medication
por: Edwards, C, et al.
Publicado: (2008)

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.
por: Sokka, T, et al.
Publicado: (2009)

Models of rheumatoid arthritis.
por: Williams, R
Publicado: (2005)

Remission and major clinical response in active rheumatoid arthritis (RA) patients after adalimumab (Humira (R)) treatment
por: Burmester, G, et al.
Publicado: (2007)

Rheumatoid arthritis: introduction.
por: Feldmann, M, et al.
Publicado: (1998)

Cardiovascular magnetic resonance characterization of myocardial and vascular function in rheumatoid arthritis patients
por: Ntusi, N, et al.
Publicado: (2018)

The immunogenetics of rheumatoid arthritis.
por: Wordsworth, B, et al.
Publicado: (1992)

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
por: Sokka, T, et al.
Publicado: (2007)

MYOCARDIAL AND VASCULAR DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS ASSESSED WITH CARDIOVASCULAR MAGNETIC RESONANCE: EVIDENCE OF INCREASED VASCULAR RISK
por: Ntusi, N, et al.
Publicado: (2013)